Boundless Bio, Inc. (BOLD) stock
BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.46+0.00 (0.00%)
Close on Nov 12, 2026Market cap $55.96MP/E –Yield –
Boundless Bio cash
Cash and short-term investments held at the end of each period.
Boundless Bio's cash was $62.90M at Sep 30, 2026. For fiscal 2025 it was $107.60M, down 29.3% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $107.60M | -29.3% |
| FY2024 | Dec 31, 2024 | $152.10M | +25.4% |
| FY2023 | Dec 31, 2023 | $121.31M | +956.4% |
| FY2022 | Dec 31, 2022 | $11.48M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $62.90M | -46.5% |
| Q2 FY2026 | Jun 30, 2026 | $72.60M | -42.9% |
| Q1 FY2026 | Mar 31, 2026 | $92.80M | -32.9% |
| Q4 FY2025 | Dec 31, 2025 | $107.60M | -29.3% |
| Q3 FY2025 | Sep 30, 2025 | $117.60M | -29.6% |
| Q2 FY2025 | Jun 30, 2025 | $127.10M | -29.1% |
| Q1 FY2025 | Mar 31, 2025 | $138.30M | +31.9% |
| Q4 FY2024 | Dec 31, 2024 | $152.10M | +25.4% |
| Q3 FY2024 | Sep 30, 2024 | $167.10M | +697.1% |
| Q2 FY2024 | Jun 30, 2024 | $179.30M | +334.0% |
| Q1 FY2024 | Mar 31, 2024 | $104.88M | +398.1% |
| Q4 FY2023 | Dec 31, 2023 | $121.31M | +956.4% |
| Q3 FY2023 | Sep 30, 2023 | $20.96M | – |
| Q2 FY2023 | Jun 30, 2023 | $41.32M | – |
| Q1 FY2023 | Mar 31, 2023 | $21.06M | – |
| Q4 FY2022 | Dec 31, 2022 | $11.48M | – |
See a number that looks wrong?